Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Content Filter
Choose a Topic
ADC
Agreement
Appointment
Big Data
Biologics
Biomanufacturing
Biosimilars
Business
Capacity Expansion
CDMO
Cell and Gene Therapy
Clinical Trials
Collaboration
Continuous Manufacturing
CRISPR
CRO
DNA
Drug Delivery
Drug Development
Drug Discovery
Engineering
Equipment
Excipients
Facility
Formulation
Generics
Healthcare
Immunotherapy
Innovation
Investment
Licensing
Logistics
Manufacturing
Market Expansion
Market Intelligence
Market Prediction
Oncology
Oral Solid Dosage
Orphan Drugs
Packaging
Parenterals
Patient Centric
Preclinical
Process Development
Regulatory
Research
Serialization
Stem Cells
Strategic Partnership
Supply Chain
Vaccine
Intermediates
×
Choose a Section
Features
News
Press Releases
Roundtable
In Conversation
Nice Consulting
Virtual Panel
Trends Trending
×
Choose an Issue
Issue Q3 2022
Issue Q2 2022
Issue Q1 2022
Issue Q4 2020
Issue Q3 2020
Issue Q2 2020
Issue Q1 2020
Issue Q4 2019
Issue Q3 2019
Issue Q2 2019
Issue Q1 2019
Issue Q4 2018
Issue Q3 2018
Issue Q2 2018
Issue Q1 2018
Issue Q4 2017
Issue Q3 2017
Issue Q2 2017
Issue Q1 2017
Issue Q4 2016
Issue Q3 2016
Issue Q2 2016
Issue Q1 2016
Issue Q4 2015
×
5752 Articles Available
1
240
Can't find what you're looking for? Try our
advanced search
.
3D Cell Culture
Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine
PAO-09-23-CL-02
Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support
CDMO
Redesigning ANDA or Novel Drug Products at All Stages for the U.S. Market
PAO-08-23-CL-06
Real-World Data
How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?
PAO-09-23-RT-01
Industry Wisdom
What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?
PAO-09-23-RT-02
Nitrosamine Impurities
Addressing the Evolving Nitrosamine Contamination Issue
PAO-09-23-CL-07
Data Management
Who is Using FAIR Data in Life Sciences R&D Today?
PAO-09-23-CL-05
Cell Therapy
Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies
PAO-08-23-CL-04
Data Management
Embracing FAIR Data on the Path to AI-Readiness
PAO-09-23-CL-03
Insect Cell Expression
Innovations in Baculovirus–Insect Cell Expression Systems
PAO-09-23-CL-01
Decentralized Clinical Trials
Innovating DCTs Through Application and Cross-Functional Delivery
PAO-07-23-CL-02
Supply Chain Management
DeltaTrak’s FlashTrak Global Supply Chain Management System Ready for Sweden’s Export-Oriented Economy
PR-M08-23-02
Aseptic Fill/Finish
Webinar: Capitalizing on CDMO Expertise in Aseptic Fill/Finish, Presented by Samsung Biologics
PAO-08-23-PATV-02
CDMO Partnerships
Webinar: A Developer's Guide to Partnering With the Right CDMO, Presented by Samsung Biologics
PAO-08-23-PATV-01
Business Leadership
Wheeler Bio Appoints Marc Helouin as Chief Quality and Regulatory Officer
PR-M08-23-01
Viscosity Reduction
Viscosity Reduction with An Excipient Platform and Feasibility Testing Service
PAO-08-23-CL-03
Clinical and Commercial Manufacturing
Reach the Patient Quicker with GBI’s Manufacturing Solutions
PAO-08-23-CL-02
Alternative Excipient
Preparing Today for a Potential Ban on Titanium Dioxide in Pharmaceutical Drug Products
PAO-08-23-CL-01
New Integrated mRNA Offering
Building on Experience and Investing in an Integrated mRNA Offering
PAO-07-23-CL-03
Risk Management in mRNA Manufacture
Managing Risk in Cutting-Edge mRNA Therapeutics
PAO-07-23-CL-04
Continuous Processing
US Food and Drug Administration (FDA) Purchase the LiFT System from DIANT® Pharma INC.
PR-M07-23-03
CDMO Selection
Fina Biosolutions Selects Scorpius BioManufacturing for Production of cGMP CRM197
PR-M07-23-02
Quality Culture
Does Your Biologics CDMO Truly Have a Culture of Quality?
PAO-07-23-CL-07
CMC
The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies
PAO-07-23-CL-05
1
240
»